Breadcrumb Home Yale Technologies De Novo Pyrimidine Synthesis Inhibition for the Treatment of ARID1A Mutated Ovarian Cancers and Other Solid Tumors Yale Lifesciences PitchFest 2021 12/03/2021 De Novo Pyrimidine Synthesis Inhibition for the Treatment of ARID1A Mutated Ovarian Cancers and Other Solid Tumors Download Pitch Presentation Huang, Gloria.pdf (704.22 KB) Investigators Gloria Huang, MD, FACOG Associate Professor of Obstetrics, Gynecology & Reproductive Sciences
